Cannabis hyperemesis syndrome
Pro Research Analysisby 
Searched over 200M research papers
Understanding Cannabis Hyperemesis Syndrome (CHS)
Introduction to Cannabis Hyperemesis Syndrome
Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by recurrent episodes of severe nausea, vomiting, and abdominal pain in individuals who use cannabis chronically. Despite cannabis's well-known antiemetic properties, CHS presents a paradox where chronic use leads to cyclical vomiting, often relieved by hot showers or baths Schreck2017Perisetti2020Soriano-Co2010.
Epidemiology and Demographics
CHS predominantly affects young adults, with a higher prevalence in males who have been using cannabis daily for several years Schreck2017Soriano-Co2010. The syndrome was first reported in 2004, and since then, the number of cases has been increasing, likely due to the rising global cannabis use and its legalization in various regions Perisetti2020Lua2019.
Clinical Presentation and Diagnosis
Symptoms and Diagnostic Criteria
Patients with CHS typically present with intractable nausea, vomiting, and abdominal pain. A unique feature of CHS is the compulsive use of hot showers or baths to alleviate symptoms Schreck2017Perisetti2020Soriano-Co2010. Diagnosis is often challenging due to the lack of specific biomarkers and the paradoxical nature of cannabis's effects. Elevated urinary cannabis metabolite concentrations can support the diagnosis, as seen in a study where most patients had high levels of THC-COOH .
Differential Diagnosis
CHS should be considered in the differential diagnosis of cyclic vomiting syndrome, especially in patients with a history of chronic cannabis use. It is crucial to differentiate CHS from other gastrointestinal disorders to avoid unnecessary diagnostic procedures and treatments .
Pathophysiology
The exact mechanism underlying CHS remains unclear. However, it is hypothesized that chronic cannabis use disrupts the endocannabinoid system (ECS), which plays a role in regulating nausea and vomiting. The biphasic effect of cannabis, where low doses act as antiemetics and high doses as pro-emetics, may contribute to the development of CHS Perisetti2020Harris2010. Additionally, the thermosensitivity observed in CHS patients suggests a possible involvement of the hypothalamic cannabinoid system .
Management and Treatment
Immediate Management
The most effective immediate relief for CHS symptoms is hot showers or baths. However, this is a temporary measure, and the definitive treatment is the cessation of cannabis use Schreck2017Soriano-Co2010Lua2019. Supportive care, including intravenous fluids and antiemetics, may be necessary during acute episodes, although traditional antiemetics are often ineffective Schreck2017Peixoto2023.
Long-term Management
Long-term management involves educating patients about the condition and the importance of abstaining from cannabis. Studies have shown that symptoms typically resolve with cannabis cessation, and recurrence is common if cannabis use is resumed Soriano-Co2010Wightman2023. In palliative care settings, where complete abstinence may not be feasible, reducing cannabis use might help manage symptoms .
Conclusion
Cannabis Hyperemesis Syndrome is an increasingly recognized condition associated with chronic cannabis use. Despite its paradoxical nature, understanding and recognizing CHS is crucial for effective management. The primary treatment is cannabis cessation, which leads to symptom resolution. As cannabis use continues to rise globally, awareness and education about CHS among healthcare providers and patients are essential to improve outcomes and reduce the burden on healthcare systems. Further research is needed to elucidate the pathophysiology and develop targeted therapies for CHS.
Sources and full results
Most relevant research papers on this topic